  See all
 |
Articles: Major Studies |
Accelerating botulism therapeutic product development in the Department of Defense
Drug Development Research, 06/19/09
Cytokinetics Announces the Initiation of a First-Time-In-Humans, Phase I Clinical Trial of CK-2017357
Cytokinetics, 06/19/09
Free full text
Frequency of diagnosis and treatment of allergic rhinitis among adults with asthma in Germany, France, and the UK: National Health and Wellness Survey
Current Medical Research and Opinion, 06/18/09 Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
Neuropsychopharmacology, 06/18/09 In vitro drug release and in vivo human X-ray studies of ileo-cecal targeting budesonide fast disintegrating tablet
Drug Development and Industrial Pharmacy, 06/16/09 Review of Serum Voriconazole Concentrations and Correlations with Adverse Events and Efficacy
Journal of Pharmacy Technology, 06/16/09 Bayer completes Phase II Study on BAY 94-9172 in Alzheimer's Disease Imaging
BayNews International, 06/15/09
Free full text
Successful phase II/III trial of new therapy for adrenal insufficiency
b3c newswire, 06/15/09 Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer with Recurrent Symptomatic
Malignant Ascites
Sanofi-aventis, 06/12/09
Free full text
New study results further support the efficacy and safety of a once daily Mirapexin/Sifrol (pramipexole) formulation at all stages of Parkinson`s disease, with added benefits in the reduction of off-time
Boehringer Ingelheim, 06/11/09
Free full text
Recruitment completed in zalutumumab head and neck cancer pivotal study
Genmab, 06/11/09
Free full text
Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
BioMarin, 06/10/09
Free full text
Abbott's TRILIPIX (fenofibric acid) in Combination with Rosuvastatin Calcium Helps Patients with Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Abbott, 06/09/09 Study shows GSK's novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight
GlaxoSmithKline, 06/09/09
Free full text
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study
Active Biotech, 06/09/09
Free full text
Fyi from human genome sciences: glaxosmithkline study shows gsk's novel diabetes treatment syncria (albiglutide) improves glucose control, reduces weight
Human Genome Sciences, 06/09/09
Free full text
Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Bristol Myers-Squibb Company, 06/08/09
Free full text
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
Amgen, 06/08/09
Free full text
Actemra (tocilizumab) studies to be featured at the european league against rheumatism (eular) congress
Roche, 06/05/09
Free full text
AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
172 Available Pages
|
|
